IMS Health is the leading global provider of business intelligence and strategic support for the pharmaceutical and healthcare industries. At IMS, we transform billions of pharmaceutical transactions into customized strategic insights using leading-edge technologies to assist our clients in optimizing their performances and advancing the quality of healthcare.
In many markets, including the South East and East Asia region, we are the only information provider that covers 100 percent of prescription distribution channels. We gather data from virtually every prescription distribution channel - from wholesalers and hospitals to retailers and mail order firms.
In addition, we are able to add value by offering business intelligence and strategic consulting services that support pharmaceutical decision making in 18 Asia-Pacific countries, including the key markets of China, Korea and Taiwan. Our unique mix of experience, expertise, global reach and unmatched data assets makes us the right partner for our clients in planning strategies and tactics, evaluating alliances, considering new markets, preparing drug launches, making investment decisions, or deploying sales forces.
To date, IMS has a presence in 10 countries in the South East / East Asia Region, namely China, Hong Kong, Indonesia, Korea, Malaysia, The Philippines, Singapore, Taiwan, Thailand and Vietnam. These markets are fast growing and have high potential.
The breakdown of the forecast of the Asian market in the year 2005 is as follows:
The market size includes Korea, Taiwan, The Philippines, Indonesia, Thailand, Hong Kong, Malaysia and Singapore.
To perform successfully in these markets, pharmaceutical companies need to equip themselves with a deep understanding of the industry trends and insights that IMS is uniquely able to provide.
IMS South East/East Asia is strategically positioned to help your business maximise results. Click here to learn more about the solutions we offer.